Summary
- ARKG component added to flagship fund.
- Meaningful position would top 7% of outstanding shares.
- Company fits usual pattern with large losses and cash burn.
For further details see:
Verve Therapeutics: Cathie Wood Adds To ARKKFor further details see:
Verve Therapeutics: Cathie Wood Adds To ARKKMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
Market:
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual...
- KALYDECO ® is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the CFTR gene - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has gra...
2024-04-25 09:45:00 ET While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last, although historically speaking, these periods tend to significantly outl...